|Last Price||Today's Change||52-Week Range||Trading Volume|
|6.89||-0.16 (-2.27%)||6.36 - 10.32||748.8 thousand (Below Avg)|
Market data as of 4:00PM 07/28/14. Quotes are delayed by at least 15 min.
Spectrum Pharmaceuticals Completes Enrollment in Phase 2 Trial of SPI-2012 - A Novel Long-Acting Granulocyte Colony Stimulating Factor (GCSF) to Treat Chemotherapy-induced Neutropenia
05/28/2014 7:00 AM ET